PKCδ inhibition normalizes the wound-healing capacity of diabetic human fibroblasts
Mogher Khamaisi, George L. King(Joslin Diabetes Center), Thomas Thomou(Joslin Diabetes Center), Chenyu Huang, Hillary A. Keenan(Joslin Diabetes Center), Sayaka Katagiri(Joslin Diabetes Center), Kyoungmin Park(Joslin Diabetes Center), Yasutaka Maeda(Kyushu University), Danielle Eschuk(Harvard University), Ana Tellechea(Beth Israel Deaconess Medical Center), Dennis P. Orgill(Brigham and Women's Hospital), Qian Li(University of North Carolina at Chapel Hill), Weier Qi(Joslin Diabetes Center), Amy J. Wagers(Harvard University), Aris Veves(Beth Israel Deaconess Medical Center)
Cited by 89
Related Papers
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
|New England Journal of Medicine|1994|3.8k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k
Retinopathy in Diabetes
|Diabetes Care|2004|1.1k